Stage M2 – Experimental validation of a novel biaxial method enabling the targeted delivery of ultrasound for the treatment of brain disorders
Neurostimulation is an exciting and rapidly expanding field for the treatment of neurodegenerative and psychiatric disorders such as epilepsy, Parkinson’s disease or various forms of neuropathic pain. Current neurostimulation strategies, relying on diffuse electrical or magnetic fields to affect the activity of neural structures, are however limited by their invasiveness when it comes to the stimulation of specific deep brain regions. Ever since the reversible effects of ultrasound on neural structures were reported in the first third of the 20th century, ultrasound-based methods potentially offering minimally-invasive and targeted neurostimulation modalities were conceptualized. Already widely exploited in medical imaging and therapeutic applications, the propagation properties inherent to this mechanical wave, allow for the focusing of acoustic energy non-invasively and at depth within biological tissues. With the advent of complex electronic systems, focus steering has also been made possible, opening the doors to novel treatment approaches based on the fact that acoustic energy could be deposited to various locations within tissues without requiring any mechanical movement of the ultrasound emitting transducer.
Although focus steering would be highly valuable in the context of neurostimulation, as it would allow the quasi-simultaneous stimulation of various functional regions, standard multi-element-based solutions are discarded when confronted to the space constraints inherent to this setting. In this context, we tested through numerical simulations in collaboration with the University of Calgary (Canada) and the company NovusTX, the application of a novel biaxial driving method providing focus steering capabilities to piezoelectric transducers while keeping electrical driving complexity sufficiently low.
More informations on the link below.